Characteristics of CD4+CD25+Foxp3+ regulatory T cells in patients with multiple organ dysfunction syndrome.

Study of Aetiology and Outcome in Acute Febrile Illness Patients with Multiple Organ Dysfunction Syndrome.

Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome.

Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.

Survival in fully manifest multiple organ dysfunction syndrome.

Regulatory T cells and vascular dysfunction.

Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients.

Role of CD8(+) regulatory T cells in organ transplantation.

Circulating angiopopietin-1 correlates with the clinical course of multiple organ dysfunction syndrome and mortality in patients with severe sepsis.

Prognostic value of different scoring models in patients with multiple organ dysfunction syndrome associated with acute COPD exacerbation.

Circulating regulatory T cells in patients with severe fever with thrombocytopenia syndrome.

Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis.

Impairment of Circulating CD4⁺CD25⁺GARP⁺ regulatory T cells in patients with acute coronary syndrome.

Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells.

Early changes within the lymphocyte population are associated with the development of multiple organ dysfunction syndrome in trauma patients.

Blood hemoperfusion with resin adsorption combined continuous veno-venous hemofiltration for patients with multiple organ dysfunction syndrome.

Correction: Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.

Combined use of non-biological artificial liver treatments for patients with acute liver failure complicated by multiple organ dysfunction syndrome.

Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells.

Multiple organ failure syndrome.

Application of bedside continuous blood purification in patients with multiple organ dysfunction syndromes.

T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients.

Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells.

CD4+ FOXP3+ Regulatory T Cells Exhibit Impaired Ability to Suppress Effector T Cell Proliferation in Patients with Turner Syndrome.

Suggest Documents

Study of Aetiology and Outcome in Acute Febrile Illness Patients with Multiple Organ Dysfunction Syndrome.

Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome.

Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.

Survival in fully manifest multiple organ dysfunction syndrome.

Regulatory T cells and vascular dysfunction.

Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients.

Role of CD8(+) regulatory T cells in organ transplantation.

Circulating angiopopietin-1 correlates with the clinical course of multiple organ dysfunction syndrome and mortality in patients with severe sepsis.

Prognostic value of different scoring models in patients with multiple organ dysfunction syndrome associated with acute COPD exacerbation.

Circulating regulatory T cells in patients with severe fever with thrombocytopenia syndrome.

Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis.

Impairment of Circulating CD4⁺CD25⁺GARP⁺ regulatory T cells in patients with acute coronary syndrome.

Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells.

Early changes within the lymphocyte population are associated with the development of multiple organ dysfunction syndrome in trauma patients.

Blood hemoperfusion with resin adsorption combined continuous veno-venous hemofiltration for patients with multiple organ dysfunction syndrome.

Correction: Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.

Combined use of non-biological artificial liver treatments for patients with acute liver failure complicated by multiple organ dysfunction syndrome.

Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells.

Multiple organ failure syndrome.

Application of bedside continuous blood purification in patients with multiple organ dysfunction syndromes.

T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients.

Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells.

CD4+ FOXP3+ Regulatory T Cells Exhibit Impaired Ability to Suppress Effector T Cell Proliferation in Patients with Turner Syndrome.

Characteristics of CD4+CD25+Foxp3+ regulatory T cells in patients with multiple organ dysfunction syndrome.

Recommend Documents

Follow Us